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Luc Jordaens, MD, PhD; Dominic A.M.J. Theuns, PhD
Background—Implantable cardioverter-defibrillator (ICD) shock is a critical event to patients associated with well-being
after implantation, although other factors may play an equally important role. We compared the association of shock and
the patient’s preimplantation personality with health status, using a prospective study design.
Methods and Results—Consecutively implanted ICD patients (n383; 79% men) completed the Type D Scale at baseline
and the Short-Form Health Survey 36 (SF-36) at baseline and 3, 6, and 12 months. Of all patients, 23.5% had a Type
D personality and 13.8% received a shock during follow-up. Shocked patients reported significantly poorer health status,
as did Type D patients. Health status patterns were poorest in patients with combined Type D personality and shock
during follow-up. Shock during follow-up was a significant independent associate of poorer health status for 4 of 8
subscales of the SF-36 and the Mental Component Summary (all P.05), with shocked patients scoring between 2.60
to 13.30 points lower than nonshocked patients. Type D personality was an independent associate of poor
postimplantation health status for 6 of 8 of the SF-36 subscales and the Mental Component Summary, with Type D
patients scoring between 2.12 to 8.02 points lower, adjusting for demographic and clinical characteristics.
Conclusions—ICD shock and the patient’s preimplantation personality disposition were equally important associates of
health status 12 months after implantation. Identification of the patient’s personality profile before ICD implantation
may help identify subsets of patients who may need additional care, for example, with a psychosocial component. (Circ
Cardiovasc Qual Outcomes. 2012;5:373-380.)
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Implantable cardioverter-defibrillator (ICD) shocks may beassociated with poor patient-rated health status and quality
of life, although the patient’s response to shock may vary
considerably from relief that the ICD works to severe distress
including posttraumatic stress1–3 and in extreme cases, a wish
to have the ICD explanted.4 It is generally accepted that an
ICD shock is a critical event to individual patients, although
empirical results on the association between shock and
patient-reported outcomes (PROs; ie, anxiety, depression, and
quality of life) are inconsistent.1–2 These mixed results may in
part be attributed to smaller sample sizes in some of the
observational studies2 but they also suggest that the relation-
ship between ICD shock(s) and PROs may be neither linear
nor straightforward.5,6
The psychological response to a shock is likely to be
associated with a complex interplay of factors and not with
shocks alone. In addition, patients may become distressed in
the absence of shocks. Factors associated with poor PROs
include symptomatic heart failure,7–9 the number of shocks
received,10 the appropriateness of the shock and associated
pain,4 the patient’s preimplant personality disposition, and
concerns about the device.2,11 Although results with respect to
the relationship between sex and PROs are mixed,12 indica-
tion for ICD implantation seems to play less of a role in
explaining the variability in PROs.13
Knowledge of the subsets of ICD patients at risk of poor
PROs is important for the optimal treatment and care of these
patients, as anxiety and high levels of ICD concerns alone and
in combination with personality factors,14,15 depression,16 and
posttraumatic stress17 are associated with the occurrence of
ventricular tachyarrhythmia’s and survival in ICD patients.
Preliminary evidence also indicates that poor health status
may be related to morbidity and mortality in ICD patients.18
In the current study, we focused on health status as the
PRO rather than on anxiety and depression, as less attention
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has been given to health status and particularly the associates
of poor health status in this patient cohort. To disentangle the
association between ICD shocks and health status versus
other potentially competing factors, we made a head-to-head
comparison between shocks and the patient’s preimplantation
personality as associates of health status, using a prospective
study design with health status assessed at baseline and 3, 6,
and 12 months postimplantation. We had specifically chosen
to single out the distressed (Type D) personality as the
primary competing associate for a head-to-head comparison,
because the role of preimplantation factors, such as person-
ality, tend to be neglected in arrhythmia research despite their
potential significant contribution to variability in PROs and
clinical outcome.14,15,19
WHAT IS KNOWN
● Although anxiety and poor health status have been
attributed to ICD shocks, little is known about the
association between ICD shocks, patient health sta-
tus, and the patient’s preimplantation psychological
profile and personality type.
WHAT THE STUDY ADDS
● This article demonstrates that although ICD shocks
are generally associated with impaired health status,
the patient’s preimplantation psychological profile
and personality disposition also help explain vari-
ability in health status among ICD patients.
● With new algorithms being introduced in ICD pro-
gramming to reduce the incidence of shocks, it seems
timely to focus on other factors, including psycho-
logical, that influence health status to optimize the
outcomes of ICD patients.
Methods
Patients and Study Design
A consecutive cohort of patients implanted with a first-time ICD or
ICD with cardiac resynchronization therapy (CRT-D) between Au-
gust 2003 and May 2010 at the Erasmus Medical Center, Rotterdam,
The Netherlands, comprised the study sample. All patients were
enrolled in the Mood and personality as precipitants of arrhythmia in
patients with an Implantable cardioverter-defibrillator: A prospective
Study (MIDAS). Patients on the waiting list for heart transplantation,
with a life expectancy of 1 year, with a history of psychiatric
illness other than affective/anxiety disorders, or with insufficient
knowledge of the Dutch language were excluded from the study. The
MIDAS study protocol was approved by the medical ethics commit-
tee of the Erasmus Medical Center. The study was conducted
according to the ethical guidelines of the Helsinki Declaration, as set
out by the World Medical Association. All patients received written
and oral information about the study and provided written informed
consent.
Procedure
An ICD nurse approached all patients for study participation,
provided they fulfilled the inclusion criteria. Patients completed a set
of standardized and validated self-report questionnaires at baseline
(ie, 1 day before ICD implantation) and at 3, 6, and 12 months
postimplantation. Information on demographic and clinical charac-
teristics was gathered at baseline from patients’ medical records or
obtained via purpose-designed questions. Information on device
therapy was obtained by device interrogation.
Measures
Baseline Demographic and Clinical Variables
Information on demographic variables included sex, age, marital
status, and education. Information on clinical variables included
indication for ICD therapy (primary versus secondary), CRT, left
ventricular ejection fraction 35%, QRS 120 ms, coronary artery
disease, symptomatic heart failure (defined as New York Heart
Association (NYHA) functional classes III and IV), atrial fibrillation,
diabetes mellitus, smoking, cardiac (ie, amiodarone, diuretics, an-
giotensin-converting enzyme inhibitors, -blockers, digoxin, and
statins) and psychotropic medication.
Health Status
Health status was assessed with the Short Form Health Survey
(SF-36).20 The SF-36 consists of 36 items that contribute to the
following 8 subscales: physical functioning, role functioning–physi-
cal, bodily pain, social functioning, mental health, role functioning–
emotional, vitality, and general health. Scores on the subscales are
linearly converted into a score between 0 and 100, with a higher
score indicating better health status. A high score on the bodily pain
subscale reflects absence of pain. Based on the SF-36, it is also
possible to derive a Physical Component Summary (PCS) and a
Mental Component Summary (MCS) score, with all subscales
contributing to both summary scores based on a priori determined
weights. The SF-36 has been validated in several Dutch populations
and has a good internal consistency, with a mean Cronbach  of 0.84
across all subscales.21 Patients were asked to complete the SF-36 at
baseline and at 3, 6, and 12 months postimplantation.
Type D Personality
Type D personality was assessed at baseline with the 14-item Type
D Scale (DS14), which is a self-report measure that patients
complete within 5 minutes.22 Type D personality is a stable person-
ality construct defined as a general propensity to psychological
distress that typifies individuals who experience increased negative
emotions while not wanting to share these emotions with others due
to fear of rejection.19,22 Items are rated on a 5-point Likert scale from
0 to 4. The DS14 can be summed into a 7-item negative affectivity
subscale (eg, “I often feel unhappy”) and a 7-item social inhibition
subscale (eg, “I am a closed kind of person”), both with a score range
from 0 to 28. A standardized cutoff score of 10 was used to define
Type D caseness,22 which has been shown to be the optimal cutoff
using item response theory.23 The DS14 is a valid and internally
consistent measure (Cronbach : negative affectivity0.88; social
inhibition0.86) and is stable over time (3-month test-retest reliabil-
ity: negative affectivity, r0.72; social inhibition, r0.82).22 Type
D personality is not confounded by indicators of disease severity,
such as left ventricular ejection fraction, which makes it an ideal
measure to use in cardiac and other somatic disease populations.24
ICD Therapy During Follow-Up
Information on delivered ICD therapy was recorded in our institu-
tional database from the time of implantation. All patients were seen
at 3-month intervals at our outpatient electrophysiology clinic. In
addition, patients were advised to contact our clinic as soon as
possible after a symptomatic event. Two experienced electrophysi-
ologists from the electrophysiology staff of the Erasmus Medical
Center reviewed and categorized all spontaneous episodes with
stored electrograms that resulted in ventricular therapies. In the
event of disagreement, a third reviewer was consulted and a
consensus was reached. Arrhythmias were classified as ventricu-
lar tachyarrhythmia or atrial tachyarrhythmia without a coexistent
ventricular arrhythmia. Therapy triggered by ventricular
tachyarrhythmias was considered appropriate, whereas therapy de-
livered for atrial tachyarrhythmias (including atrial fibrillation, atrial
flutter, atrial tachycardia, and sinus tachycardia) or T-wave over-
sensing and noise were considered inappropriate.
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Statistical Analysis
Patients with missing values either on demographic and clinical
variables or on health status at baseline were excluded from analyses.
Baseline characteristics were compared by means of the 2 test
(Fisher exact test when appropriate) for nominal variables and
Student t test for continuous variables. Differences between the
averages of the categories of shock (either appropriate or inappro-
priate shock versus no shock) over time were statistically tested
using generalized linear mixed modeling repeated-measures analysis
of variance (ANOVA) with a split-plot–like design that considers
interaction effects between shock and time. Similar analyses were
performed to test the trends for differences on average between
categories of Type D versus non–Type D personality and combina-
tions of shock and Type D. For these separate analyses on the
association between shock and health status and Type D personality
and health status, respectively, we adjusted only for the baseline
measurement of the outcome variable (ie, the specific health status
domain at baseline) but not for clinical and demographic variables.
We used generalized linear mixed modeling repeated measures
analysis of covariance (ANCOVA) to assess the effects of shocks
during the follow-up period and Type D personality on changes in
health status controlling for the effects of demographic and clinical
variables. Since a correlation between follow-up assessments on
health status can be presumed, the usual regression analysis that
assumes independent observations is not an appropriate method.25 In
addition to taking care of the fact that measurements are correlated,
the mixed modeling approach does not require that each of the
subjects should have an equal number of follow-up measurements.
As such, patients can be kept in the analysis even if they did not
complete all assessments, thereby reducing potential bias that occurs
when patients are lost to attrition during follow-up.25 The linear
mixed model used in our analysis assumes a normal distribution for
the random effect that accounts for the correlation between obser-
vations within a subject. Because the interest of the analysis is
mainly on the fixed effects (comparison of groups), valid inferences
can be obtained even when the random effects might have been
incorrectly assumed to be normally distributed.26,27 For each of the
SF-36 subscales and the PCS and the MCS, we fitted a separate
model using linear mixed models advanced statistical option in
SPSS. A priori based on the literature, we decided to enter the
following covariates in adjusted analyses (in addition to shock and
Type D personality and the interaction of Type D personality by
shocks) in each of the random intercept models: sex, age, marital
status, education, indication for ICD implantation, CRT, coronary
artery disease, atrial fibrillation, diabetes mellitus, smoking, amiod-
arone, -blockers, psychotropic medication, and baseline health
status. If the interaction of Type D personality by shocks was not
statistically significant, the model was run and results presented
without the interaction. This approach was adopted to avoid the
inclusion of covariates that may be statistically significant due to the
specific sample under study, as also recommended by others.28 All
tests were 2-tailed, and a probability value 0.05 was used to
indicate statistical significance. Estimates are reported with corre-
sponding 95% confidence intervals (CI). All data were analyzed
using PASW Statistics 17 statistical software (PASW IBM Corp,
Armonk, NY).
Results
Participants Versus Nonparticipants on
Baseline Characteristics
Of 448 patients eligible and approached for study participa-
tion, we had to exclude 67 (14.9%) from statistical analyses
because of 1 of the following reasons: No score on the SF-36
or on the DS14 at baseline (n29) or lack of information on
demographic or clinical variables (n38). Cases excluded
from analyses did not differ systematically from included
cases (n383) on baseline characteristics, except for ex-
cluded cases being more likely to have a lower educational
level (P0.05).
Patient Baseline Characteristics
Baseline characteristics for the total sample and stratified by
shocks (both appropriate and inappropriate) are displayed in
Table 1. The prevalence of atrial fibrillation (P0.035) and
diabetes mellitus (P0.046) was higher among patients who
received 1 or more shocks during follow-up, whereas shocked
patients were less likely to have an ICD due to a primary
prevention indication (P0.014). In contrast, the prescription
of angiotensin-converting enzyme inhibitors was lower
among patients who received a shock during follow-up as
compared with nonshocked patients (P0.04). No other
systematic differences were found on demographic and clin-
Table 1. Patient Baseline Characteristics for the Total Sample
and Stratified by the Occurrence of Any Shock (Either Appropriate
or Inappropriate) During the 12-Month Follow-Up Period*
Shocks (Any) During Follow-Up
Characteristics
Total
(n383)
Yes
(n53)
No
(n330) P Value
Demographics
Men 304 (79.4) 43 (81.1) 261 (79.1) 0.73
Age, y, meanSD 57.712.0 57.813.8 57.711.7 0.97
Single/no partner 25 (6.5) 4 (7.5) 21 (6.4) 0.75
Lower education† 95 (24.8) 14 (26.4) 81 (24.5) 0.77
Clinical
Primary prevention
indication
252 (65.8) 27 (50.9) 225 (68.2) 0.014
CRT 111 (29.0) 13 (24.5) 98 (29.7) 0.44
LVEF 35% 284 (85.8) 38 (88.4) 246 (85.4) 0.61
QRS 120 ms 190 (49.6) 32 (60.4) 158 (47.9) 0.09
CAD 224 (58.5) 28 (52.8) 196 (59.4) 0.37
Symptomatic heart
failure‡
124 (32.4) 18 (34.0) 106 (32.1) 0.79
Atrial fibrillation 87 (22.7) 18 (34.0) 69 (20.9) 0.035
Diabetes mellitus 53 (13.8) 12 (22.6) 41 (12.4) 0.046
Smoking 45 (11.7) 9 (17.0) 36 (10.9) 0.20
Medication
Amiodarone 69 (18.0) 8 (15.1) 61 (18.5) 0.55
Diuretics 218 (56.9) 27 (50.9) 191 (57.9) 0.34
ACE inhibitors 270 (70.5) 31 (58.5) 239 (72.4) 0.04
-blockers 299 (78.1) 39 (73.6) 260 (78.8) 0.40
Digoxin 58 (15.1) 12 (22.6) 46 13.9) 0.10
Statins 217 (56.7) 26 (49.1) 191 (57.9) 0.23
Psychotropic
medication
60 (15.7) 9 (17.0) 51 (15.5) 0.78
Psychological
Type D personality 90 (23.5) 14 (26.4) 76 (23.0) 0.59
CRT indicates cardiac resynchronization therapy; LVEF, left ventricular
ejection fraction; CAD, coronary artery disease; and ACE, angiotensin-
converting enzyme.
*Results are presented as n (%) unless otherwise indicated.
†Education 13 years.
‡Defined as New York Heart Association classes III and IV.
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ical baseline characteristics between shocked and nonshocked
patients.
Health Status Stratified by Shocks and Type D
Personality (Unadjusted Analysis)
Of all patients, 23.5% (90/383) had a Type D personality and
13.8% (53/383) received a shock during the 12-month
follow-up period. Of all patients, 10.7% (41/383) had an
appropriate shock and 3.9% (15/383) an inappropriate shock.
Because of the low incidence of inappropriate shocks, further
analyses were conducted with any shock (ie, whether appro-
priate or inappropriate).
Mean health status scores on the different SF-36 subscales
and the PCS and the MSC during the follow-up period,
stratified by the occurrence of shocks and Type D personality,
are displayed in Figures 1 and 2, respectively. Patients
receiving a shock during the follow-up period scored about
14 points (13.82 [95% CI, 26.08 to 1.55]) lower on
mental health status as compared with nonshocked patients
and about 5 points (5.14 [95% CI, 9.73 to 0.56]) lower
on role functioning–physical. There were no significant
differences between shocked and nonshocked patients on the
other 6 of 8 SF-36 domains nor on the PCS and the MCS (all
P0.05) (Figure 1).
A similar pattern was visible for Type D patients as
compared with non–Type D patients (Figure 2), although
differences were significant for 5 of 8 health status domains
(physical functioning: 5.40 [95% CI, 10.63 to 0.17];
role functioning–physical: 16.66 [95% CI, 26.23 to
7.08]; social functioning: 6.71 [95% CI, 11.65 to
1.77]; mental health: 4.44 [95% CI, 8.19 to 0.68];
role functioning–emotional: 12.04 [95% CI, 20.08 to
4.01]) and the PCS (2.35 [95% CI, 4.57 to 0.13]) and
the MCS (3.48 [95% CI, 5.76 to 1.20]), with Type D
patients scoring between about 4 to 12 points lower on
specific health status domains and summary scores.
The probability values from repeated-measures analyses
ANCOVAs that consider interaction effects between shock
and time indicated significant interaction effects only for the
subscales role functioning–emotional (P0.023) and general
health (P0.024). Similar analyses among Type D categories
showed that the differences on the averages for Type D and
Figure 1. Mean scores on health status, stratified by the occurrence of shocks.
Figure 2. Mean scores on health status, stratified by Type D personality.
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non–Type D patients significantly change over time only for
the subscales physical functioning (P0.019) and bodily pain
(P0.017).
Figure 3 shows the trends for the SF-36 subscales and the
PCS and the MCS separately for the 4 different combinations
of shock and Type D categories: (1) shock and Type D; (2)
shock and non–Type D; (3) no shock and Type D; and (4) no
shock and non–Type D). Using (4) no shock and non–Type D
as the reference group, there were no significant differences
between this group and group (2) shock and non–Type D on
any of the SF-36 subscales nor on the PCS and the MCS (all
P0.05). Significant differences were found between the
reference group and group (3) no shock and Type D on role
functioning–physical (15.90 [95% CI, 26.16 to 5.69]),
social functioning (6.94 [95% CI, 12.20 to 1.67], role
functioning–emotional (11.81 [95% CI,20.42 to3.20])
and the MSC (3.18 [95% CI,5.65 to0.72]), with the no
shock and Type D group scoring between 3 to about 16 points
lower on these specific health status domains. Statistically
significant differences were also found between group (4) no
shock and non–Type D and group (1) shock and Type D on
role functioning–physical (30.46 [95% CI, 54.62 to
6.3]), mental health (12.22 [95% CI, 21.33 to 3.11]),
role functioning–emotional (20.17 [95% CI, 40.15 to
0.20]) and the MSC (6.53 [95% CI, 11.92 to 1.14]),
with scores between 6 to 30 points lower on these domains in
the shock and Type D group. Patterns for the 4 combinations
of categories indicated the poorest health status in shocked
patients with a Type D personality and the best health status
in nonshocked non–Type D patients. The patterns for non-
shocked Type D patients and shocked non–Type D patients
showed similar trends, suggesting that generally shock and
Type D personality may contribute almost equally to the
variability in health status scores.
Health Status Stratified by Shocks and Type D
Personality (Adjusted Analysis)
In Table 2, estimates with accompanying 95% CI for each of
the predictor variables (ie, shock and Type D personality)
adjusted for other covariates for each subscale of the SF-36
and the PCS and the MCS are displayed. The occurrence of
shock in the first year after implantation was a significant
predictor of poorer health status during the follow-up period
for 4 of 8 of the SF-36 subscales and the MCS (all P0.05).
Type D personality was an independent predictor of postim-
plantation health status for 6 of 8 subscales and the MCS (all
P0.05). Shocked patients scored between 2.60 to 13.30
points lower on these domains as compared with nonshocked
patients. A similar pattern was found for Type D patients as
compared with non–Type D patients, with Type D patients
scoring 2.12 to 8.02 points lower. The interaction effect for
Type D personality by shocks was not significant for any of
the SF-36 domains nor the PCS and the MCS (results not
shown). Hence, the models were run and are presented
without the interaction effect. The interactions with time for
either shock or Type D were not significant for any of the
SF-36 domains nor the PCS and the MCS in all models
shown in Table 2.
We also evaluated the separate effect of appropriate versus
inappropriate shocks on all health status domains and the PCS
and the MCS in multivariable models. We found no statisti-
cally significant influence of inappropriate shocks on out-
comes (results not shown), which was probably due to the
low incidence of inappropriate shocks during the follow-up
period. For appropriate shocks, the impact on health status
remained the same as presented in Table 2, with a trend
toward the influence of appropriate shocks on health status
being stronger as compared with examining the joint influ-
ence of any shock on health status outcomes (results not
shown).
Discussion
In the current study, we sought to examine the relationship
between ICD shock(s) and the patient’s preimplantation
personality as associates of health status, using a prospective
study design with multiple assessments of health status up to
12 months after ICD implantation. We found that both ICD
shock(s) and Type D personality were independently associ-
Figure 3. Mean scores on health status, stratified by the occurrence of shock and Type D personality.
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ated with poor health status. At 12 months after implantation,
shock during follow-up was independently associated with 4
domains of the SF-36 (ie, role functioning–physical domain,
social functioning, mental health, and vitality) and the MCS,
whereas Type D personality was an independent associate of
6 domains of the SF-36 (ie, physical functioning, role
functioning–physical, bodily pain, social functioning, mental
health, and role functioning–emotional) and the MCS, adjust-
ing for demographic and clinical characteristics and baseline
health status. Patients receiving a shock or patients with a Type
D personality scored between 2 to 13 points lower on some of
the health status domains as compared with nonshocked or
non–Type D patients. The combination of shock and Type D
personality was generally associated with the poorest health
status at 12 months.
Our mixed findings on the association between shock(s)
and health status are in line with other studies, such as the
large-scale primary prevention trials, Defibrillators in Nonische-
mic Cardiomyopathy Treatment Evaluation (DEFINITE),29
Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT),30
and Multicenter Automatic Defibrillator Implantation Trial II
(MADIT-II),18 as they also found an association with some
but not all health status domains using the SF-36 or the
shortened SF-12 version. It is possible that ICD shock is only
associated with specific health status domains, although this
is speculative. Alternatively, the SF-36 and the SF-12 are not
the most sensitive measures to evaluate the impact of shock(s)
on patients, as they are generic rather than disease-specific, with
some scales also only being composed of 2 items, which leaves
room for little variability in scores. However, in a previous
cross-sectional Danish study of 566 ICD patients, we also found
no association between shock and scores on the Florida Patient
Acceptance Survey (FPAS), which is a disease-specific measure
of device acceptance and quality of life.31
In a previous cross-sectional study in a different cohort of
ICD patients, we demonstrated that the risk of anxiety and
depression may depend more on the preimplantation person-
ality of the patient than on shock(s), with an anxiety preva-
lence of 61% in nonshocked Type D patients versus 32% in
shocked non–Type D patients, and a depression prevalence of
57% in nonshocked Type D patients versus 19% in shocked
non–Type D patients.32 Others have found that Type D but
not shocks are associated both with interviewer-rated and
patient self-report anxiety.33 The results of the current pro-
spective study extend those findings, demonstrating that
personality remains associated with health status over time
and that Type D patients report poorer health status than
non–Type D patients despite improvements during the course
of the 12-month follow-up period. In particular, the combi-
nation of ICD shock(s) and Type D personality was associ-
ated with the poorest health status at 12 months on all health
status domains. This is consistent with our findings on
anxiety and depression, which also showed that the preva-
lence of psychological morbidity was highest in this subset of
patients with 72% being anxious and 67% being depressed if
patients had a Type D personality and received a shock.32
Given that the patient’s preimplantation personality is an
important correlate of postimplant health status and that Type
D personality has been associated with the occurrence of
ventricular tachyarrhythmia, survival,14,15 and poor health
status with an increased risk of mortality in ICD patients,18 it
is important to identify this subset of high-risk patients in
clinical practice. Information about the patient’s personality
profile may help to target nursing and psychosocial care to
the needs of the individual patient, as Type D patients and in
particular Type D patients who receive a shock after implant
might benefit from adjunctive intervention, such as cardiac
rehabilitation34 in combination with behavioral or psycholog-
ical interventions that have been shown to reduce psycholog-
ical distress in ICD patients.35
The limitations of the current study should be acknowl-
edged. We had to exclude 67 patients from statistical analyses
because some refused to participate and others had missing
information on either demographic, clinical variables, or
measures of health status at baseline. This despite the use of
the latest statistical technique to analyze prospective data,
which allows that patients be kept in the analysis even if they
did not complete all follow-up assessments.25 However,
patients excluded from analyses did not differ systematically
from included patients on baseline characteristics, except for
nonparticipants being more likely to have a lower educational
level as compared with participants. We had no information
on changes in comorbidity status nor changes in medication
during the 12-month follow-up period, which might poten-
tially have influenced the outcome. Finally, given the study
design, it is not possible to infer causation and whether
shocks lead to poor health status or vice versa.
In conclusion, the results of the current study show that
both ICD shock(s) and the patient’s preimplantation person-
ality disposition are important associates of health status 12
months after implantation, independent of demographic and
clinical characteristics and baseline health status. Given that
the incidence of shocks has decreased substantially with new
programming algorithms and software,36 it seems timely to
focus on other factors in addition to shocks when identifying
patients at high risk of poor health status and poor psycho-
logical functioning.2
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